TABLE 3.
Variable | All | Local cohort (n = 30) | Literature cohort (n = 106) | P-value |
Sex | ||||
Male | 76(55.9%) | 19(63.3%) | 57(53.8%) | 0.352 |
Female | 60(44.1%) | 11(36.7%) | 49(46.2%) | |
Location | ||||
Single lobe | 90(76.3%) | 20(66.7%) | 70(79.5%) | 0.152 |
Multiple lobes | 28(23.7%) | 10(33.3%) | 18(20.5%) | |
Symptoms | ||||
Seizures | 61(45.2%) | 9(30.0%) | 52(49.5%) | 0.058 |
Others | 74(54.8%) | 21(70.0%) | 53(50.5%) | |
Texture | ||||
Solid | 43(37.1%) | 12(41.4%) | 31(35.6%) | 0.846 |
Cystic | 46(39.7%) | 11(37.9%) | 35(40.2%) | |
Solid-Cystic | 27(23.2%) | 6(20.7%) | 21(24.1%) | |
WHO Grade | ||||
II | 68(50%) | 17(56.7%) | 51(48.1%) | 0.408 |
III | 68(50%) | 13(43.3%) | 55(51.9%) | |
Surgery resection | ||||
Subtotal resection | 25(18.4%) | 10(33.3%) | 15(14.2%) | 0.017 |
Gross total resection | 111(81.6%) | 20(66.7%) | 91(85.8%) | |
Irradiation | ||||
Yes | 62(45.6%) | 14(46.7%) | 48(45.3%) | 0.893 |
No | 74(54.4%) | 16(53.3%) | 58(54.7%) | |
Recurrence | ||||
Yes | 37(28.5%) | 9(30%) | 28(28%) | 0.831 |
No | 93(71.5%) | 21(70%) | 72(72%) | |
Outcome | ||||
Alive | 115(89.8%) | 26(86.7%) | 89(90.8%) | 0.51 |
Dead | 13(10.2%) | 4(13.3%) | 9(9.2%) |